Current and future strategies for radiation therapy in gastric cancer

被引：4

作者：

Mesci, Aruz ^{[1
]}

Wong, Rebecca K. S. ^{[1
]}

机构：

[1] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Dept Radiat Oncol, 610 Univ Ave, Toronto, ON M5G 2M9, Canada

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2022年 / 125卷 / 07期

关键词：

gastric cancer; multimodality; nanotechnologies; quality; radiotherapy; theranostics; PHASE-III TRIAL; PREOPERATIVE CHEMORADIOTHERAPY; NEOADJUVANT CHEMORADIOTHERAPY; ESOPHAGEAL CANCER; CLINICAL-TRIAL; FOLLOW-UP; RADIOTHERAPY; CHEMOTHERAPY; SURGERY; CHEMORADIATION;

D O I：

10.1002/jso.26880

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Gastric cancers are heterogeneous. There are important differences between gastric and junctional tumors and a focus on evidence based on true gastric cancers is important to guide treatment decision and the design of innovative strategies. We present key evidence shaping the current use of radiotherapy, discuss technical radiotherapy considerations that are important to consider in multidisciplinary decision-making, and highlight selected research strategies including radiotherapeutic advances, theranostic approaches and key ongoing clinical trials to watch that will shape the role of radiotherapy in gastric cancers for the future.

引用

页码：1161 / 1175

页数：15

共 66 条

[1] Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: Degree of pathologic response and not clinical parameters dictated patient outcome
Ajani, JA
Mansfield, PF
Crane, CH
Wu, TT
Lunagomez, S
Lynch, PM
Janjan, N
Feig, B
Faust, J
Yao, JC
Nivers, R
Morris, J
Pisters, PW
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1237 - 1244
[2] Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma
Ajani, JA
Mansfield, PF
Janjan, N
Morris, J
Pisters, PW
Lynch, PM
Feig, B
Myerson, R
Nivers, R
Cohen, DS
Gunderson, LL
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 2774 - 2780
[3] Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): Quality of combined modality therapy and pathologic response
Ajani, Jaffer A.
Winter, Kathryn
Okawara, Gordon S.
Donohue, John H.
Pisters, Peter W. T.
Crane, Christopher H.
Greskovich, John F.
Anne, P. Rani
Bradley, Jeffrey D.
Willett, Christopher
Rich, Tyvin A.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3953 - 3958
[4] Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Al-Batran, Salah-Eddin
Homann, Nils
Pauligk, Claudia
Goetze, Thorsten O.
Meiler, Johannes
Kasper, Stefan
Kopp, Hans-Georg
Mayer, Frank
Haag, Georg Martin
Luley, Kim
Lindig, Udo
Schmiegel, Wolff
Pohl, Michael
Stoehlmacher, Jan
Folprecht, Gunnar
Probst, Stephan
Prasnikar, Nicole
Fischbach, Wolfgang
Mahlberg, Rolf
Trojan, Joerg
Koenigsmann, Michael
Martens, Uwe M.
Thuss-Patience, Peter
Egger, Matthias
Block, Andreas
Heinemann, Volker
Illerhaus, Gerald
Moehler, Markus
Schenk, Michael
Kullmann, Frank
Behringer, Dirk M.
Heike, Michael
Pink, Daniel
Teschendorf, Christian
Loehr, Carmen
Bernhard, Helga
Schuch, Gunter
Rethwisch, Volker
von Weikersthal, Ludwig Fischer
Hartmann, Joerg T.
Kneba, Michael
Daum, Severin
Schulmann, Karsten
Weniger, Joerg
Belle, Sebastian
Gaiser, Timo
Oduncu, Fuat S.
Guentner, Martina
Hozaeel, Wael
Reichart, Alexander
[J]. LANCET, 2019, 393 (10184) : 1948 - 1957
[5] The Role of Cancer Stem Cells in Radiation Resistance
Arnold, Christoph Reinhold
Mangesius, Julian
Skvortsova, Ira-Ida
Ganswindt, Ute
[J]. FRONTIERS IN ONCOLOGY, 2020, 10
[6] A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer
Bamias, Aristotelis
Karina, M.
Papakostas, P.
Kostopoulos, I.
Bobos, M.
Vourli, G.
Samantas, E.
Christodoulou, Ch.
Pentheroudakis, G.
Pectasides, D.
Dimopoulos, M. A.
Fountzilas, G.
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (06) : 1009 - 1021
[7] Comprehensive molecular characterization of gastric adenocarcinoma
Bass, Adam J.
Thorsson, Vesteinn
Shmulevich, Ilya
Reynolds, Sheila M.
Miller, Michael
Bernard, Brady
Hinoue, Toshinori
Laird, Peter W.
Curtis, Christina
Shen, Hui
Weisenberger, Daniel J.
Schultz, Nikolaus
Shen, Ronglai
Weinhold, Nils
Keiser, David P.
Bowlby, Reanne
Sipahimalani, Payal
Cherniack, Andrew D.
Getz, Gad
Liu, Yingchun
Noble, Michael S.
Pedamallu, Chandra
Sougnez, Carrie
Taylor-Weiner, Amaro
Akbani, Rehan
Lee, Ju-Seog
Liu, Wenbin
Mills, Gordon B.
Yang, Da
Zhang, Wei
Pantazi, Angeliki
Parfenov, Michael
Gulley, Margaret
Piazuelo, M. Blanca
Schneider, Barbara G.
Kim, Jihun
Boussioutas, Alex
Sheth, Margi
Demchok, John A.
Rabkin, Charles S.
Willis, Joseph E.
Ng, Sam
Garman, Katherine
Beer, David G.
Pennathur, Arjun
Raphael, Benjamin J.
Wu, Hsin-Ta
Odze, Robert
Kim, Hark K.
Bowen, Jay
[J]. NATURE, 2014, 513 (7517) : 202 - 209
[8] Comparisons of Gastric Cancer Treatments: East vs. West
Bickenbach, Kai
Strong, Vivian E.
[J]. JOURNAL OF GASTRIC CANCER, 2012, 12 (02) : 55 - 62
[9] Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach
Bittoni, Alessandro
Scartozzi, Mario
Giampieri, Riccardo
Faloppi, Luca
Bianconi, Maristella
Mandolesi, Alessandra
Del Prete, Michela
Pistelli, Mirco
Cecchini, Luca
Bearzi, Italo
Cascinu, Stefano
[J]. PLOS ONE, 2013, 8 (11):
[10] Bleeker M., 2021, RADIOTHER ONCOL, V166, P126

← 1 2 3 4 5 6 7 →